Richard U. de Schutter, Director at Valeant Pharmaceuticals International, Inc. (VRX), bought 10,000 shares at $15.34 ($153K) on 2018-03-08, disclosed to the SEC on 2018-03-12.
Open-market purchase of $153k VRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BHC | BUY | 2018-09-17 | $3.0M | — | Filing → |
| VRX | BUY | 2018-07-03 | $218K | — | Filing → |
| VRX | BUY | 2018-05-17 | $327K | — | Filing → |